Clinical Trial Update: Avalglucosidase Alfa Pregnancy Study

View source ↗

Summary

The Avalglucosidase alfa pregnancy study (NCT05734521) sponsored by Sanofi is currently recruiting to evaluate its use in Pompe disease during pregnancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Drugs mentioned

• Avalglucosidase alfa (avalglucosidase alfa)

Snippet

Sponsor: Sanofi | Conditions: Pompe Disease, Pregnancy | Status: RECRUITING